Thank you, Mr. Chair.
Thank you to all the witnesses for being here.
Dr. Kalyan, you referred in your opening statement and remarks to infection-acquired immunity. How clear is the data regarding its strength and durability, and how does it compare to vaccine-acquired immunity?